Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intracoronary Reopro for Microvascular Function in NSTEMI
NCT02105870Unknown
- Sponsor
- University of Melbourne
- Start
- Feb 2012
- Primary completion
- Jun 2014
- Countries
- 1
01
Overview
Randomised, double-blind trial of abciximab in non-ST-elevation myocardial infarction (NSTEMI), sponsored by University of Melbourne. Primary endpoint: Index of Microvascular Resistance at 3 hours. Status: unknown.
02
Drugs
abciximab
03
Conditions
non-ST-elevation myocardial infarction (NSTEMI)
Beyond the preview
Go deeper on NCT02105870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02105870.